Company / Shareholders' Equity
PALVELLA THERAPEUTICS, INC. Shareholders' Equity History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$62.6M
FY2024
5-year range
-$93.8M / $62.6M
FY2020-FY2024
Trend
+184.1%
vs FY2023
Sector context
#181 of 213
Health Care
What the data says
PALVELLA THERAPEUTICS, INC.'s shareholders' equity of $63M is lower than 85% of companies in the Health Care sector (FY2024). Improved from -$94M to $63M over the past 2 years.
Based on SEC 10-K filings.
$63M in FY2024 with a 5-year CAGR of +4.0%.
Improved from -$94M to $63M over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +26.4%
- 5-Year CAGR
- +4.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 15% in Health CareTop 85% of 213This company $62.6M Sector average $2.5B
▼
-97.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +4.0%, indicating consistent growth.
- In FY2024, shareholders' equity increased 184.1% year-over-year.
- Ranks #181 out of 213 companies in the Health Care sector.
- Lowest shareholders' equity in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 1.15 (distress zone, below 1.8 threshold)
- Strong profit margin: 43.7%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $62.6M | +184.1% |
| FY2023 | -$74.5M | +20.6% |
| FY2022 | -$93.8M | -402.2% |
| FY2021 | $31.0M | -39.6% |
| FY2020 | $51.4M | +0.0% |
| FY2019 | $51.4M | +345.7% |
| FY2018 | $11.5M | -54.3% |
| FY2017 | $25.2M | +0.0% |
| FY2016 | $25.2M | -19.0% |
| FY2015 | $31.1M | +72.9% |
As of FY2024 · SEC 10-K Annual Filings · Updated Jun 30, 2026